Heparin Maker Shenzhen Hepalink to Acquire U.S. Supplier

Shenzhen Hepalink Pharmaceutical agreed to acquire Scientific Protein Laboratories for $337.5 million to strengthen the quality of Shenzhen's blood clot prevention drug.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304483804579281984009095954.html?mod=pls_whats_news_us_business_f

via IFTTT